Nitric oxide: a drug target for glaucoma revisited.
Sign Up to like & getrecommendations! Published in 2019 at "Drug discovery today"
DOI: 10.1016/j.drudis.2019.05.033
Abstract: A reduction in intraocular pressure (IOP) is the only recognized therapy for glaucoma. Hence, drugs exhibiting ocular hypotensive effects are important targets for antiglaucomatous drug development. IOP is determined by the equilibrium of aqueous humor… read more here.
Keywords: trabecular meshwork; oxide drug; drug; glaucoma ... See more keywords